British Columbia Investment Management’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-35,500
Closed -$315K 819
2022
Q3
$315K Hold
35,500
﹤0.01% 798
2022
Q2
$449K Hold
35,500
﹤0.01% 786
2022
Q1
$672K Hold
35,500
﹤0.01% 807
2021
Q4
$1.25M Hold
35,500
0.01% 781
2021
Q3
$1.3M Hold
35,500
0.01% 777
2021
Q2
$1.39M Buy
35,500
+4,900
+16% +$141K 0.01% 789
2021
Q1
$864K Hold
30,600
0.01% 806
2020
Q4
$980K Hold
30,600
0.01% 788
2020
Q3
$988K Hold
30,600
0.01% 752
2020
Q2
$844K Buy
30,600
+3,300
+12% +$71.6K 0.01% 754
2020
Q1
$487K Buy
27,300
+1,000
+4% +$24.1K 0.01% 724
2019
Q4
$659K Hold
26,300
﹤0.01% 806
2019
Q3
$469K Buy
26,300
+1,500
+6% +$31.2K ﹤0.01% 770
2019
Q2
$546K Hold
24,800
﹤0.01% 785
2019
Q1
$758K Buy
24,800
+100
+0.4% +$2.49K 0.01% 757
2018
Q4
$570K Buy
+24,700
New +$768K 0.01% 755

Other funds holding HCM

British Columbia Investment Management's HCM Position: Q4 2022 in Review

British Columbia Investment Management sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 35,500 shares — an estimated $315K sold.

British Columbia Investment Management first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $1.39M in Q2 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • British Columbia Investment Management reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • British Columbia Investment Management sold 35,500 HUTCHMED shares in Q4 2022, an estimated $315K.
  • British Columbia Investment Management first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
  • British Columbia Investment Management's HUTCHMED position peaked at $1.39M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on British Columbia Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.